SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-14-420204
Filing Date
2014-11-21
Accepted
2014-11-20 17:31:33
Documents
3
Group Members
PS MANAGEMENT GP, LLCWILLIAM A. ACKMAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.14 TO SCHEDULE 13D d820680dsc13da.htm SC 13D/A 92238
2 EX-99.40 d820680dex9940.htm EX-99.40 17771
3 EX-99.41 d820680dex9941.htm EX-99.41 5087
  Complete submission text file 0001193125-14-420204.txt   116639
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Subject) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40724 | Film No.: 141240126
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A